UBS Oconnor LLC
- SEC CIK
- 0001132716
- Latest filing
- Aug 14, 2026
RARE holding history
Ultragenyx Pharmaceutical Inc. in every 13F filed by UBS Oconnor LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
RARE overviewAll 13F holders of RAREFull Q4 2025 holdings
- Shares (Q3 2025)
- 0
- Sold out in Q3 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 10
- Since Q1 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2025 | 0 | $0 | 0.0% | −31,861−100.0% | Sold out | Holders |
| Q2 2025 | 31,861 | $1.16M | <0.1% | −55,950−63.7% | Reduced | Holders |
| Q1 2025 | 87,811 | $3.18M | 0.1% | +65,527+294.1% | Added | Holders |
| Q4 2024 | 22,284 | $937.5K | <0.1% | +1,015+4.8% | Added | Holders |
| Q3 2024 | 21,269 | $1.18M | <0.1% | −13,859−39.5% | Reduced | Holders |
| Q2 2024 | 35,128 | $1.44M | <0.1% | −7,478−17.6% | Reduced | Holders |
| Q1 2024 | 42,606 | $1.99M | 0.1% | −14,350−25.2% | Reduced | Holders |
| Q4 2023 | 56,956 | $2.72M | 0.1% | −19,959−25.9% | Reduced | Holders |
| Q3 2023 | 76,915 | $2.74M | <0.1% | +9,567+14.2% | Added | Holders |
| Q2 2023 | 67,348 | $3.11M | 0.1% | +8,072+13.6% | Added | Holders |
| Q1 2023 | 59,276 | $2.38M | 0.1% | +59,276 | New | Holders |